Vivek Podder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vivek Podder has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arun Maharaj
Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA
1 shared publication - Khalid Ahmad Qidwai
Miami Cancer Institute, Baptist Health South Florida, Miami, United States
1 shared publication - Manmeet Singh Ahluwalia
Baptist Health South Florida
1 shared publication - Sonikpreet Aulakh
Department of Medical Oncology, West Virginia University, Morgantown, WV, USA
1 shared publication - Tulika Ranjan
Dartmouth Hitchcock Medical Center and Clinics, Lebanon, NH 03756, USA
1 shared publication - Zouina Sarfraz
Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA
1 shared publication
Latest Publications
- Open Access
Gaps in Diagnosis, Treatment, and Outcomes Among Patients with Brain Tumors in the United States: A State-of-the-Art Review
Brain tumors, both malignant and non-malignant, represent a persistent global health challenge. Differences in diagnosis, treatment, and outcomes are influenced by race, ethnicity, socioeconomic status (SES), and geographical location. Brain and central nervous system (CNS) tumors rank 19th in global cancer incidence and 12th in cancer-related mortality. U.S. Incidence is higher in females and individuals with greater socioeconomic means, contrasting with global patterns where males are more affected. Glioblastoma has a wide variation in incidence and survival by state, with rural regions showing higher mortality despite lower incidence, often due to reduced access to specialized care. Non-Hispanic Black children with CNS tumors experience higher mortality than their White peers, even after adjusting for SES. Outcomes are generally poorer in low- and middle-income countries, where healthcare infrastructure remains limited. Biological and genetic differences may also influence treatment response and tumor behavior across population groups. This review outlines key variations in brain tumor care, with a key focus on the United States, and emphasizes the need for patient-centered strategies to ensure timely diagnosis, consistent treatment, and improved outcomes.
Open AccessGaps in Diagnosis, Treatment, and Outcomes Among Patients with Brain Tumors in the United States: A State-of-the-Art Review
Brain tumors, both malignant and non-malignant, represent a persistent global health challenge. Differences in diagnosis, treatment, and outcomes are influenced by race, ethnicity, socioeconomic status (SES), and geographical location. Brain and central nervous system (CNS) tumors rank 19th in global cancer incidence and 12th in cancer-related mortality. U.S. Incidence is higher in females and individuals with greater socioeconomic means, contrasting with global patterns where males are more affected. Glioblastoma has a wide variation in incidence and survival by state, with rural regions showing higher mortality despite lower incidence, often due to reduced access to specialized care. Non-Hispanic Black children with CNS tumors experience higher mortality than their White peers, even after adjusting for SES. Outcomes are generally poorer in low- and middle-income countries, where healthcare infrastructure remains limited. Biological and genetic differences may also influence treatment response and tumor behavior across population groups. This review outlines key variations in brain tumor care, with a key focus on the United States, and emphasizes the need for patient-centered strategies to ensure timely diagnosis, consistent treatment, and improved outcomes.